DuPont is a global leader in probiotics science and manufacturing. We are innovative solvers, drawing on deep consumer insights and a broad product portfolio to help our customers turn challenges into high-value business opportunities.
For us, innovation requires extensive portfolios,scientific tests and a profound understanding of technologies, our customer’s value chain and the consumer market.
ROCHESTER, NY, March 28, 2019 – DuPont today announced it has completed construction on a new, state-of-the art probiotics fermentation unit at its Rochester, New York, facility. The unit, now largest in the world, is part of a multiphase nearly $100 million investment to expand probiotics capacity and enhance the company’s leadership in delivering high-quality, clinically documented probiotics to dietary supplement and food and beverage manufacturers.
DuPont Releases Clinical Study Results that Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations
KANTVIK, Finland, March 21, 2019 – Results from a clinical trial performed by Taverniti and colleagues from the University of Milan (IT) suggest that ingesting higher doses of multispecies probiotic formulations may permit higher, earlier and longer recovery of probiotics in feces of healthy adults.
DuPont Nutrition & Health and Lonza Specialty Ingredients Announce Joint Agreement in Human Milk Oligosaccharides
COPENHAGEN, Denmark, Feb. 27, 2019 – DuPont Nutrition & Health and Lonza Specialty Ingredients announce an agreement under which the leading biotechnology and specialty ingredient company Lonza will manufacture and supply CARE4U™ 2’-FL – a human milk oligosaccharide (HMOs). This strategic manufacturing collaboration reinforces market confidence in the supply and premium quality of this specialty ingredient.
KUNSHAN, CHINA, December 13, 2018 – Today, DuPont Nutrition & Health presented on the latest developments on clinical research, market insights and trends on global probiotics products at the 3rd Probiotics and Health Medical Science Summit. Top food safety and clinical experts in China exchanged the standards and safety of probiotics and domestic clinical research results with focus on digestion, immunity, women’s & children’s health, and internal microbiota regulation. The summit attracted close to 50 chief physicians from the Department of Gastroenterology, Nutrition, Dermatology, Endocrinology and Internal Medicine of leading Third-Level Grade-A hospitals across the country.
WILMINGTON, Del., Dec. 11, 2018 – DuPont Nutrition & Health has released new findings from a clinical study of a synbiotic dietary supplement that gives hope to overweight consumers at risk of health complications. Combining the benefits of a proven probiotic with a prebiotic fiber, HOWARU® Shape has proven potential to improve metabolic health while supporting weight loss.
KANTVIK, Finland, September 26, 2018 – A collaborative clinical study between DuPont Nutrition & Health, the University of Virginia and 4Pharma Ltd indicates that nasal microbiota may influence the viral load, host innate immune response and clinical symptoms during rhinovirus infection.
DuPont Nutrition & Health has R&D centers across the world focusing on different fields to build global synergies and provide powerful support for local customers. We adopt internationally recognized high-quality standards for production and supply chains across the world, to ensure that our probiotic products are safe, stable and effective. We provide “turnkey” solutions for customers covering every aspect including product analysis, development, production and marketing, to help customers shorten the product development cycle and reduce supply chain complexity, and to eventually let the end-consumers benefit from our efforts.